We will provide women with the
breast cancer Diagnostics-as-a-Service
they are seeking
The Blue Box Biomedical Solutions
THE PROBLEM
THE SOLUTION
WE'RE BUILDING A PAIN-FREE, RADIATION-FREE AND ACCESSIBLE BREAST CANCER TEST FOR THEM.
SENSITIVITY
ACCURACY
SPECIFICITY
MAMMOGRAPHY
IN WOMEN AGED <50
73%
58%
88%
THE BLUE BOX
IN WOMEN AGED <50
85%
79%
71%
OUR MISSION
Women aged 20-45 cannot get screened for BC because existing solutions are unreliable. However, they want to. At The Blue Box, we have built a urine-based pain-free, low-cost, sensitive, radiation-free device to make breast cancer detection accessible.
In 2024, we’ll launch into the market, bringing The Blue Box to private gynaecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.
Incubated at...
Supported by...
Do you want to be the first to know when the blue box will hit the market?
Subscribe to our newsletter and never miss out on
The Blue Box journey!
